Ir ao contido
CureSight O Dispositivo De Tratamento De Ollos Preguiceiros de Kobi Kor

O deseño CureSight O Dispositivo De Tratamento De Ollos Preguiceiros de Kobi Kor é un estimado gañador do moi prestixioso 2022 A' Design Award de Ferro na Categoría de Competición Deseño de Dispositivos e Equipos Médicos.


FerroProduto Médico· 2022

CureSight O Dispositivo De Tratamento De Ollos Preguiceiros

de Kobi Kor

Cliente: Novasight

Gañador do A' Design Award de Ferro na Categoría Produto Médico

22,237

Gañador de Premio Verificado

Verificar o Estado do Premio para #133911

Cores

O Deseño

Sobre CureSight O Dispositivo De Tratamento De Ollos Preguiceiros

O proceso de deseño de CureSight centrouse na creación dun produto e unha solución de tratamento que teña un impacto social positivo e axude aos pacientes, na súa maioría nenos, a evitar a incomodidade e a vergoña que supón o tratamento tradicional co parche ocular. O deseño tamén subliña que o aspecto e sensación do produto son esenciais para motivar e empoderar aos nenos. A inspiración para o deseño do estilo veu dos aparellos tecnolóxicos que os nenos adoran usar e xogar con el. O deseño da forma proporciona un aspecto elegante e moderno para un produto de dispositivos médicos.

O Recoñecemento

Sobre o A' Design Award de Ferro

CureSight O Dispositivo De Tratamento De Ollos Preguiceiros gañou o A' Design Award de Ferro, un recoñecemento prestixioso outorgado a bos deseños que cumpren os requisitos profesionais e industriais esperados de creacións ben deseñadas. Os gañadores Ferro demostran a gran habilidade, a alta especialización, a comprensión experta e a capacidade creativa dos seus creadores. Espérase que CureSight O Dispositivo De Tratamento De Ollos Preguiceiros sexa unha creación moi apreciada, admirada e querida que é práctica e innovadora. Este deseño gañador do A' Design Award de Ferro integra as mellores prácticas do sector e ten características técnicas competentes ligadas ao saber facer e ao talento. CureSight O Dispositivo De Tratamento De Ollos Preguiceiros é respectado pola súa minuciosidade e está deseñado para proporcionar melloras na calidade de vida que axudan a facer do mundo un lugar mellor.

Detrás do deseño

Kit de prensa

Créditos, membros do equipo e detalles técnicos proporcionados polo deseñador.

Propiedades Únicas
The curesight is a powerful solution with great potential to totally change the treatment of lazy eye condition, with the important advantage of treating the lazy eye from the comfort of home and by watching any tv or streaming video content.
This healthcare solution for lazy eye condition integrates high-end technologies for eye-tracking and ai software tools for smart analyzing of the lazy eye condition and providing personal custom treatment. The gold standard care for lazy eye is placing a patch over the strong eye, an old-fashioned solution that suffers from very low compliance.
Dimensións e Embalaxe
product net dimensions
Height 230mm
Width 390mm
Depth 60mm
Etiquetas
amlyopia, lazy eye, medical device, product design, social impact, degital healthcare
Tecnoloxía de Produción
The design activity started with a brainstorming meeting to learn more about the problem from the clinical and user needs aspects, and to outline the main big limitations of today's treatment methods.
We also discussed the ergonomics and usability needs to be able to provide the best treatment.
during the design process, we tested several design concepts both aesthetically and with physical mockups,
Production technologies include aluminum CNC machining and anodize plating, for the front bezel and plastic injection for the back cover and small covers.
Reto de Deseño
The creative challenge was to dress the unique technology components with style and to provide a good user experience to the users, the specific usability needs to enable good treatment for various populations and make it an appealing and empowering treatment device, and lead to important social impact
Investigación
Following an intense effort over the last 18 months, the company officially announced that the company successfully met the primary endpoint of the CureSight randomized, controlled pivotal trial of amblyopia treatment against the gold standard patching.
This is the first-ever pivotal study in which a digital device was shown to be non-inferior to eye patching for amblyopia treatment in children.
The study also exhibited 93% adherence to the curesight treatment, as well as a 93% likelihood of the parents choosing curesight over patching.
Inspiración
The inspiration for the curesight product started from a personal experience when one of my kids needed to treat the lazy eye condition with the eye patch solution, I learned from this experience about the discomfort of wearing the eye patch for a few hours every day and especially how embarrassing it is from the social point of view.
The inspiration for the styling design came from the tech gadgets that kids love to use and play with, to provide a slick and modern design to a medical device product type, the front aluminum bezel, and the back swallowtail gives the product a clean gadget look.
Duración do Proxecto
The project started in 2019 in Tel Aviv, and finished in late 2021, the project was exhibited at the CES in January 2020 in Las Vegas
Fluxo de Operacións
The patient, most likely kids will have the fun be treated by the Curesight while watching any video content they love to watch without any degradation in quality and from the comfort of home.
Membros do Equipo
Kobi Kor
Tal Samet
Créditos das Imaxes
All images
Photograph and Illustrations: Novasight and Kobi Kor

Patrocinado

Explora Máis Alá de Designers.org

Descobre produtos, servizos e oportunidades dos nosos socios publicitarios.

O Bo Deseño Merece un Gran Recoñecemento

O A' Design Award é un recoñecemento internacional con xurado para o bo deseño. Participa no A' Design Award para ter a oportunidade de obter un recoñecemento meritocrático, gañar fama, prestixio e publicidade para o teu traballo. Nomea o teu traballo para o A' Design Award e compite polo cobizado A' Design Prize.

Nomear